Skip to main content

letter

. 1992 Mar 28;304(6830):841. doi: 10.1136/bmj.304.6830.841-a

Renal protective effect of enalapril in diabetic nephropathy.

W W Yeo, L E Ramsay, P R Jackson

PMCID: PMC1881682 PMID: 1489422

841

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Apperloo A. J., de Zeeuw D., Sluiter H. E., de Jong P. E. Differential effects of enalapril and atenolol on proteinuria and renal haemodynamics in non-diabetic renal disease. BMJ. 1991 Oct 5;303(6806):821–824. doi: 10.1136/bmj.303.6806.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
Björck S., Mulec H., Johnsen S. A., Nordén G., Aurell M. Renal protective effect of enalapril in diabetic nephropathy. BMJ. 1992 Feb 8;304(6823):339–343. doi: 10.1136/bmj.304.6823.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
Collins R., Peto R., MacMahon S., Hebert P., Fiebach N. H., Eberlein K. A., Godwin J., Qizilbash N., Taylor J. O., Hennekens C. H. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990 Apr 7;335(8693):827–838. doi: 10.1016/0140-6736(90)90944-z. [DOI] [PubMed] [Google Scholar]
Mogensen C. E. Angiotensin converting enzyme inhibitors and diabetic nephropathy. BMJ. 1992 Feb 8;304(6823):327–328. doi: 10.1136/bmj.304.6823.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
Williams P. S., Fass G., Bone J. M. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure. Q J Med. 1988 Apr;67(252):343–354. [PubMed] [Google Scholar]

ACTIONS

RESOURCES